Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by ORG Wealth Partners LLC

ORG Wealth Partners LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 43.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 190 shares of the medical equipment provider’s stock after purchasing an additional 58 shares during the quarter. ORG Wealth Partners LLC’s holdings in Intuitive Surgical were worth $99,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in ISRG. Andra AP fonden acquired a new position in shares of Intuitive Surgical during the second quarter valued at approximately $178,000. MGO One Seven LLC boosted its holdings in Intuitive Surgical by 76.2% during the second quarter. MGO One Seven LLC now owns 4,090 shares of the medical equipment provider’s stock worth $1,819,000 after buying an additional 1,769 shares in the last quarter. LPL Financial LLC boosted its holdings in Intuitive Surgical by 9.2% during the second quarter. LPL Financial LLC now owns 294,740 shares of the medical equipment provider’s stock worth $131,115,000 after buying an additional 24,715 shares in the last quarter. Jupiter Asset Management Ltd. bought a new stake in Intuitive Surgical during the second quarter worth approximately $364,000. Finally, First Turn Management LLC bought a new stake in Intuitive Surgical during the second quarter worth approximately $18,640,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In other Intuitive Surgical news, insider Jamie Samath sold 22,903 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the sale, the insider now owns 8,757 shares of the company’s stock, valued at approximately $4,597,425. This represents a 72.34 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,788,899.12. The trade was a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock valued at $25,012,927 over the last ninety days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 0.6 %

Shares of NASDAQ ISRG opened at $547.47 on Friday. Intuitive Surgical, Inc. has a 1-year low of $355.17 and a 1-year high of $556.23. The company has a market cap of $195.00 billion, a PE ratio of 88.02, a P/E/G ratio of 5.31 and a beta of 1.39. The company has a 50-day moving average of $535.93 and a two-hundred day moving average of $494.44.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Citigroup raised their target price on shares of Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, December 11th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Piper Sandler reaffirmed an “overweight” rating and issued a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $554.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.